The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

Clinical trial NCT00301366 · COMPLETED

Trial details

NCT number: NCT00301366
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2006-06-01
Primary completion: 2007-03-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.